Molecular imaging of monocrotaline-induced pulmonary vascular disease with radiolabeled linear adrenomedullin

Journal of Nuclear Medicine

Volumn 50, Issue 7, 2009, Pages 1110-1115

  Dupuis, Jocelyn ^a,b   Harel, Francxois ^a,b   Fu, Yan ^c   Quang, Trinh Nguyen ^a   Letourneau, Myriam ^c   Préfontaine, Annick ^a   Fournier, Alain ^c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Diagnosis; Imaging; Lung; Nuclear medicine; Pulmonary hypertension

Indexed keywords

ADRENOMEDULLIN RECEPTOR; ADRENOMEDULLIN TC 99M; MONOCROTALINE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAMERA; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG UPTAKE; HEART RIGHT VENTRICLE HYPERTROPHY; IN VIVO STUDY; ISOTOPE LABELING; LUNG CIRCULATION; LUNG FUNCTION; LUNG HOMOGENATE; MALE; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; RAT;

ADRENOMEDULLIN; ANIMALS; HYPERTENSION, PULMONARY; ISOTOPE LABELING; LUNG; MALE; METABOLIC CLEARANCE RATE; MONOCROTALINE; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 67650093754     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.059428     Document Type: Article

References (20)

1. McLaughlin VV, McGoon MD. Pulmonary arterial hypertension. Circulation. 2006;114:1417-1431.
2. Dschietzig T, Azad HA, Asswad L, et al. The adrenomedullin receptor acts as clearance receptor in pulmonary circulation. Biochem Biophys Res Commun. 2002;294:315-318.
3. Dupuis J, Caron A, Ruel N. Biodistribution, plasma kinetics and quantification of single-pass pulmonary clearance of adrenomedullin. Clin Sci (Lond). 2005; 109:97-102.
4. Martinez A, Miller MJ, Catt KJ, Cuttitta F. Adrenomedullin receptor expression in human lung and in pulmonary tumors. J Histochem Cytochem. 1997;45:159-164.
5. Owji AA, Smith DM, Coppock HA, et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 1995; 136:2127-2134.
6. Harel F, Fu Y, Nguyen QT, et al. Use of adrenomedullin derivatives for molecular imaging of pulmonary circulation. J Nucl Med. 2008;49:1869-1874.
7. Juaneda C, Dumont Y, Chabot J-G, Fournier A, Quirion R. Adrenomedullin receptor binding sites in rat brain and peripheral tissues. Eur J Pharmacol. 2003;474:165-174.
8. Hay DL, Howitt SG, Conner AC, Schindler M, Smith DM, Poyner DR. CL/ RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison effects of adrenomedullin(22-52), CGRP(8-37) and BIBN4096BS. Br J Pharmacol. 2003;140:477-486.
9. Reindel JF, Ganey PE, Wagner JG, Slocombe RF, Roth RA. Development of morphologic, hemodynamic, and biochemical changes in lungs of rats given monocrotaline pyrrole. Toxicol Appl Pharmacol. 1990;106:179-200.
10. Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang Q, Stewart DJ. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res. 2005;96:442-450.
11. Miniati M, Paci A, Cocci F, Ciarimboli G, Monti S, Pistolesi M. Mitochondria act as a reservoir for the basic amine HIPDM in the lung. Eur Respir J. 1996;9:2306-2312.
12. Shih W-J, Cottrill CM, Coupal JJ, O'Connor W, Kung HF, Ryo UY. Iodine-123-HIPDM lung imaging in pulmonary vein-banded pulmonary hypertension. J Nucl Med. 1990;31:668-673.
13. Gibbons C, Dackor R, Dunworth W, Fritz-Six K, Caron KM. Receptor activity-modifying proteins: RAMPing up adrenomedullin signaling. Mol Endocrinol. 2007;21:783-796.
14. Muff R, Born W, Fischer JA. Adrenomedullin selectivity of calcitonin-like receptor/receptor activity modifying proteins. Hypertens Res. 2003;26(suppl):S3-S8.
15. Fu Y, Létourneau M, Dupuis J, Fournier A. Characterization of the binding sites for the adrenomedullin in the lungs [abstract]. Biopolymers. 2007;88:558.
16. Su AI, Cooke MP, Ching KA, et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA. 2002;99:4465-4470.
17. Ono Y, Okano I, Kojima M, Okada K, Kangawa K. Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis. Biochem Biophys Res Commun. 2000;271:197-202.
18. Kurozumi T, Tanaka K, Kido M, Shoyama Y. Monocrotaline-induced renal lesions. Exp Mol Pathol. 1983;39:377-386.
19. Yoshihara F, Nishikimi T, Okano I, et al. Upregulation of intracardiac adrenomedullin and its receptor system in rats with volume overload-induced cardiac hypertrophy. Regul Pept. 2005;127:239-244.
20. Wang X, Nishikimi T, Akimoto K, Tadokoro K, Mori Y, Minamino N. Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic. J Hypertens. 2003;21:1171-1181.